IRLAB Therapeutics Receives US Patent Allowance for Parkinson’s Candidate IRL1117
IRLAB Therapeutics says it has received a US patent allowance for its Parkinson’s drug candidate IRL1117.
IRLAB Therapeutics says it has received a US patent allowance for its Parkinson’s drug candidate IRL1117.